サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：中国の卵巣がん治療薬市場
市場調査レポート
商品コード
1529143

中国の卵巣がん治療薬市場

Ovarian Cancer Treatment Drugs Markets in China

出版日
ページ情報
英文 272 Pages
納期
即納可能 即納可能とは
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.25円
中国の卵巣がん治療薬市場
出版日: 2024年08月07日
発行: Asia Market Information & Development Co.
ページ情報: 英文 272 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中国の卵巣がん治療薬の需要は、過去10年間に速いペースで伸びてきました。今後10年間も、生産・需要の両方が伸び続けると思われます。中国経済は、工業生産高・輸出入・消費者消費・設備投資が20年以上にわたり連続的に増加することにより刺激され、高速成長を維持しています。当レポートでは、中国の経済動向・投資環境・産業動向・需給動向・業界の生産能力・産業構造・マーケティングチャネル・主要な市場参入企業を分析しています。また、市場の実績データ (2013年・2018年・2023年) と長期的予測 (2028年/2033年まで) を推計しています。さらに、中国の主要メーカーのプロファイルを掲載しています。

最新の政府規制・市場情報・業界データにアクセスするため、1次調査と2次調査を中国で実施しました。データは、中国政府の刊行物、中国語の新聞・雑誌、業界団体、地方政府の産業局、業界出版物、社内のデータベースから収集しました。インタビューは中国の業界専門家、大学教授、中国のメーカーに対して実施しました。当レポートでは、経済モデルと定量的手法を適用し、市場需要と産業動向を予測しています。メートル法が使用され、金額は人民元 (RMB、現在価格) または米ドルのいずれかで表示されます。

当社の市場調査レポートは、入手困難な市場データと分析を提供します。今日、中国は世界最大の市場を有しています。驚異的な急成長を遂げる輸入市場と、世界中の企業にとってのビジネスチャンスもあります。中国での事業拡大や製品販売をお考えなら、当社の調査レポートが必要な中国市場に関する洞察と予測を提供します。

目次

第1章 イントロダクション

  • 調査範囲・手法
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
  • 主要経済指標
  • 工業生産
  • 人口・労働力
  • 直接投資
  • 対外貿易
  • 金融・税務規制
  • 銀行システムと規制
  • 外国為替
  • 税制と関税

第3章 卵巣がん治療薬産業の評価

  • 卵巣がん治療薬産業の構造
  • 市場規模
  • 市場成長の促進要因
  • 卵巣がん治療薬の販売
  • 主要メーカーの生産施設の所在地
  • 主要メーカーの販売・市場シェア
  • パクリタキセル
  • プラチナ抗がん剤
  • フルオロピリミジン
  • アントラサイクリン系抗生物質
  • 治療用抗体
  • 低分子医薬品
  • アロマターゼ阻害剤 (標的治療薬)
  • 抗エストロゲン
  • アロマターゼ阻害剤 (内分泌療法薬)
  • LH-RH
  • 人件費
  • 主な外資系企業
  • 潜在的な参入企業
  • 技術開発
  • 中国の卵巣がん治療薬の価格

第4章 卵巣がん治療薬の生産・需要

  • 概要
  • 卵巣がん治療薬の販売
  • 化学療法薬
  • パクリタキセル
  • フルオロピリミジン
  • アントラサイクリン系抗生物質
  • プラチナ抗がん剤
  • 標的治療薬
  • 治療用抗体
  • 低分子医薬品
  • アロマターゼ阻害剤 (標的治療薬)
  • 内分泌療法薬
  • 抗エストロゲン
  • アロマターゼ阻害剤 (内分泌療法薬)
  • LH-RH
  • 卵巣がん治療薬の輸入額
  • 化学療法薬
  • アントラサイクリン系抗生物質
  • フルオロピリミジン
  • パクリタキセル
  • プラチナ抗がん剤
  • 標的治療薬
  • 治療用抗体
  • 低分子医薬品
  • アロマターゼ阻害剤 (標的治療薬)
  • 内分泌療法薬
  • 抗エストロゲン
  • アロマターゼ阻害剤 (内分泌療法薬)
  • LH-RH
  • 価格動向

第5章 卵巣がん治療薬市場の展望

  • 卵巣がん治療薬市場の展望：概要
  • 政府の規制
  • 医療・保険業界の概要
  • 消費者支出の動向
  • 人口動向
  • 医療業界の動向
  • 病院数・病床数
  • 医師数・医師の診察件数

第6章 市場参入チャネル

  • 中国市場の概要
  • 中国の流通システム
  • 卵巣がん治療薬の流通チャネル
  • 交通・貨物輸送インフラ
  • 通信
  • 中国市場への参入経路
  • ライセンス契約
  • フランチャイズ
  • 電子商取引 (eコマース)
  • 商社と現地代理店
  • 現地事務所と中国の子会社
  • 独資企業

第7章 卵巣がん治療薬メーカーの一覧

  • 卵巣がん治療薬メーカーのプロファイルと一覧
図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
  • Major Foreign Investments in China

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Platinum Anticancer Drugs Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Ovarian Cancer Treatment Drugs Import

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Market Share by Drugs Classification
  • Targeted Therapy Drug Market Share by Drugs Classification
  • Endocrine Therapy Drug Market Share by Drugs Classification
  • Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Platinum Anticancer Drugs Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Placlitaxel Anticancer Drugs Import and Market Share
  • Platinum Anticancer Drugs Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
目次
Product Code: 826

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Ovarian Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Paclitaxel
  • Platinum Anticancer Drugs
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Anthracycline Antibiotics
  • Fluoropyrimidines
  • Paclitaxel
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Ovarian Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Ovarian Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Ovarian Cancer Treatment Drugs Producer Profiles and Directory